ATS (American Thoracic Society) gives this award to a mid-career candidate who is recognized for achievements in research, mentorship, clinical care, education, advocacy, or scholarship.
Investigator(s):
Denise Al Alam, PhD
Dr. Al Alam received this award as a recognition for her numerous contributions to pediatric pulmonary research, mentorship and advocacy. Her research focuses on understanding how progenitor cells of the human lung decide what mature cell type to become and when; and how these decisions are affected by congenital anomalies and prematurity. She is a pioneer in the field of human lung development and made seminal discoveries describing a novel progenitor cell population in the human developing lung.
Funding will be directed to TLI’s Institute of Respiratory Medicine and Exercise Physiology with a Research Focus on Diverse and Underserved Patient Populations
Investigator(s):
Harry Rossiter, PhD
LOS ANGELES (May 31, 2022) — The Lundquist Institute has announced that it has received a grant of $112,000 from the Johnny Carson Foundation to support the training of the next generation of chronic obstructive pulmonary disease (COPD) researchers at its Institu
Beatson Foundation award may help develop a novel technology to generate an infinite supply of insulin producing cells
Investigator(s):
Eiji Yoshihara, PhD
Eiji Yoshihara, Ph.D., Investigator at The Lundquist Institute, has received a two-year, $220,000 grant from the Beatson Foundation for a proposed study to investigate how human pancreatic β cells, responsible for making insulin in the body, achieve long-term survival and proliferation.
Investigator(s):
Eiji Yoshihara, PhD
ERRγ deletion causes rapid and progressive pancreatic atrophy
H&E staining (upper panel) and Masson’s trichrome staining (middle panel) of pancreas from control (CON) and ERRγ conditional Knock-out (cKO) cKO mice 7d after the ERR γ deletion.
Gross images of pancreas (lower panel)
We are doing this study to find out why kids with MPS have problems with their bones, joints, brains, and other parts of their body so we can come up with medications that help them.
Investigator(s):
Lynda Polgreen, MD, MS
The Study: This research study collects blood samples from healthy children and adolescents to support research on MPS (Mucopolysaccharidoses), an inherited disease caused by the body’s inability to produce specific enzymes. The missing or insufficient enzyme prevents cells from recycling waste, resulting in cells not working right throughout the body.
The non-invasive delivery device will be for use in respiratory distress syndrome (RDS), a significant cause of neonatal mortality and morbidity
Investigator(s):
Frans Walther, MD, PhD, FAAP
The Lundquist Institute’s investigator Frans Walther, MD, PhD, has received a two-year grant from the Bill & Melinda Gates Foundation in the amount of $471,858.00 to support the development of a synthetic aerosolized lung surfactant and a non-invasive delivery device for use in infant respiratory distress syndrome (RDS), a significant cause of neonatal mortality and morbidity. Newborns experiencing RDS must dramatically increase the effort to take each breath, due to lack of adequate, naturally occurring surfactant production in their lungs.
JDRF Career Development Awards are highly competitive and given to only a few promising junior researchers each year
Investigator(s):
Eiji Yoshihara, PhD
The Lundquist Institute’s investigator Eiji Yoshihara, Ph.D., has received a five-year $749,995.50 Career Development Award from JDRF (formerly known as Juvenile Diabetes Research Foundation) for his proposed study on how human β cells gain immune evasive function by environmental cues. In pre-clinical humanized models, induction of immune-evasive function in stem cell derived functional human islet-like oganoids has proven to cure diabetes by reducing the risk of graft rejection.
Jody Spillane, Sr. VP for Public Affairs, Spearheads New Program to Introduce Elementary School Students to Science
LOS ANGELES (February 24, 2022) — The Lundquist Institute today has launched an exciting new program that introduces elementary public-school students to science. The new Institute initiative began offering its science-based curriculum to elementary school students in December of 2021 and will extend its workshops through June 2022 and then continue to offer the program every semester going forward.
Research is funded by five-year, $2.29 million grant from the National Institute of Neurological Disorders and Stroke.
LOS ANGELES (February 2, 2022) — The Lundquist Institute’s investigator Lina R. Nih, PhD, and her colleagues at Penn State have received a five-year, $2.29 million grant from the National Institute of Neurological Disorders and Stroke — an institute within the National Institutes of Health — to explore the use of injectable porous biomaterials to target post-stroke immune response and promote new blood vessel and axon formation, processes known as angiogenesis and axonogenesis, respectively, at the site of the stroke.
The Lundquist Institute float in 2022 Rose Parade called “Impositive” to celebrate its 70th Anniversary.
Investigator(s):
The Lundquist Institute
The Lundquist Institute participated in this past weekend’s Tournament of Roses Parade in celebration of its 70th Anniversary. The float’s theme Impositive means having optimism in the face of seemingly impossible odds. Impositivity propels the Institute forward as it continues its long history of making incredible groundbreaking discoveries and innovations that impact the world.